Company Overview and News

 
TPG ditches $2.76-billion Fairfax takeover bid

2017-07-02 abc.net.au
US investment company TPG Capital has abandoned its $2.76-billion bid to take over Fairfax Media, clearing the way for rival bidder Hellman & Friedman to make an offer.
Upvote Downvote

 
Alex Malley, CPA Australia's 'Naked CEO' who walked off with $4.9m

2017-06-25 theage.com.au
Accountancy is meant to be the profession of sober financial clarity. The gate keepers who provide the lingua franca of commerce.
Upvote Downvote

 
Alex Malley, CPA Australia's 'Naked CEO' who walked off with $4.9m

2017-06-25 smh.com.au
Accountancy is meant to be the profession of sober financial clarity. The gate keepers who provide the lingua franca of commerce.
Upvote Downvote

 
Jack Cowin loses $600m of dough at Domino's Pizza as franchisees push for bigger slice of profits

2017-06-22 theage.com.au
Jack Cowin's extra large slice of Domino's Pizza got cold pretty quickly after peaking at a value of $1.3 billion in August last year. It has now shrunk by about $600 million in value. 
Upvote Downvote

 
Jack Cowin loses $600m of dough at Domino's Pizza as franchisees push for bigger slice of profits

2017-06-22 smh.com.au
Jack Cowin's extra large slice of Domino's Pizza got cold pretty quickly after peaking at a value of $1.3 billion in August last year. It has now shrunk by about $600 million in value. 
Upvote Downvote

 
Elliott Associates' BHP campaign a welcome boost for local activists

2017-05-22 theage.com.au
Elliott Associates' bid to convince BHP shareholders the Big Australian should change strategies is the most high-profile shareholder activist campaign seen in Australia in a long time.
Upvote Downvote

 
Elliott Associates' BHP campaign a welcome boost for local activists

2017-05-22 smh.com.au
Elliott Associates' bid to convince BHP shareholders the Big Australian should change strategies is the most high-profile shareholder activist campaign seen in Australia in a long time.
Upvote Downvote

 
TPG boosts offer for Australia’s Fairfax Media, shares leap to six-year high

2017-05-15 themalaymailonline
A TV crew films outside the Fairfax Media headquarters in Sydney May 3, 2017. — Reuters picSYDNEY, May 15 — US buyout firm TPG Capital Management today raised its cash bid for Fairfax Media Ltd, offering A$2.76 billion (RM8.85 billion) for the struggling Australian publisher and sending its shares to a six-year high.
Upvote Downvote

 
TPG boosts offer for Australia's Fairfax Media, shares leap to six-year high

2017-05-15 in.reuters
SYDNEY U.S. buyout firm TPG Capital Management on Monday raised its cash bid for Fairfax Media Ltd, offering A$2.76 billion ($2.04 billion) for the struggling Australian publisher and sending its shares to a six-year high.
Upvote Downvote

 
Bowie Tribute and 28 Other Hamptons Benefits to Hit This Summer - Bloomberg

2016-06-30 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
True believer Alex Waislitz is 'still optimistic Mesoblast will succeed'

2016-06-17 theage.com.au
Investing in biotechnology stocks is not for the weak-kneed and with shares in stem-cell developer Mesoblast skidding to fresh six-year lows this week, hanging on to its shares has increasingly become something for the true believers.
Upvote Downvote

 
True believer Alex Waislitz is 'still optimistic Mesoblast will succeed'

2016-06-17 smh.com.au
Investing in biotechnology stocks is not for the weak-kneed and with shares in stem-cell developer Mesoblast skidding to fresh six-year lows this week, hanging on to its shares has increasingly become something for the true believers.
Upvote Downvote

 
Poppy producer TPI has high hopes this year but HQ's profile stays low

2016-05-13 theage.com.au
TPI Enterprises Managing Director Jarrod Ritchie with a bag of thebaine, a narcotic raw material, which has a commercial value of about $US600 a kilogram. Photo: Pat Scala
Upvote Downvote

 
Poppy producer TPI has high hopes this year but HQ's profile stays low

2016-05-13 smh.com.au
TPI Enterprises Managing Director Jarrod Ritchie with a bag of thebaine, a narcotic raw material, which has a commercial value of about $US600 a kilogram. Photo: Pat Scala
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...